CV Lattes
ORCID
Abstract
The design of therapeutic antibodies involves optimizing their characteristics such as affinity and specificity for antigens. This process begins with obtaining the complementarity-determining regions (CDRs), usually from murine models, and inserting them into human frameworks to avoid adverse reactions. However, during the humanization stage, negative impacts on antibodies' production an…